PlainRecalls
FDA Drug Low Class III Terminated

Azacitidine for Injection, 100 mg Lyophilized Powder, Single-Dose Vials, Rx Only, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 India. Manufactured for BluePoint Laboratories. NDC 68001-0313-56

Reported: August 24, 2022 Initiated: July 27, 2022 #D-1349-2022

Product Description

Azacitidine for Injection, 100 mg Lyophilized Powder, Single-Dose Vials, Rx Only, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 India. Manufactured for BluePoint Laboratories. NDC 68001-0313-56

Reason for Recall

Subpotent Drug

Details

Units Affected
4,160 vials
Distribution
Nationwide within the USA
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Azacitidine for Injection, 100 mg Lyophilized Powder, Single-Dose Vials, Rx Only, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 India. Manufactured for BluePoint Laboratories. NDC 68001-0313-56. Recalled by Amerisource Health Services LLC. Units affected: 4,160 vials.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on August 24, 2022. Severity: Low. Recall number: D-1349-2022.